San Clemente, CA, Feb. 03, 2021 (Globe NEWSWIRE) — by using NewMediaWire — Worldwide WholeHealth Companions Corp, (OTC:GWHP) a multinational healthcare diagnostics supplier of around 70+ products and solutions with 56 presently Fda authorised and numerous accredited for export only which includes Dengue, Ebola, Zika, Malaria and also providing 1 of the most significant strains of exams for CoViD19 SARS2, announces that they are pioneers of the only biodegradable plant based mostly plastic for health-related equipment after getting provisional patent.

As the Biden administration announced on Monday a significant thrust to make rapid COVID-19 dwelling checks out there with a $230 million federal deal by means of the Department of Defense, Worldwide WholeHealth Companions Corp. (OTC:GWHP) CEO, Charles Strongo, claimed, “We understand the growth required in the in-vitro diagnostic segment and the require for extra immediate exams, and at the same time we have an understanding of that there is also a require to GO Inexperienced.”

“We took that challenge and developed a appropriate combine of plant centered material which is 100% biodegradable, to make a plastic that is biodegradable to help the health-related industry,” said Mr. Strongo.

World-wide WholeHealth Partners acknowledges the point that tens of thousands and thousands of plastic professional medical products are made use of every single thirty day period in the US alone and hundreds of thousands and thousands all over the world. Just in the US by itself, Health care facilities throughout The usa generate close to 14,000 tons (28,000,000 lbs.) of waste for each working day. Up to 25% of this is produced up of plastic merchandise.

“We know firsthand how busy the Healthcare Business is as it’s combating off health conditions, particularly during this international pandemic we felt compelled to do far more to overcome the Medical Squander dilemma by lending our biodegradable know-how,” Strongo commented.

World-wide WholeHealth Companions Corp recently entered into a License Arrangement with Charles Sturdy in which beneath the terms of the Settlement, the Corporation has the distinctive license to manufacture, market and license to be manufactured the only Biodegradable plastic for clinical equipment.

President Biden’s Government Order on Developing the COVID-19 Pandemic Screening Board was not too long ago applauded by Charles Strongo, CEO of World wide WholeHealth Associates Corp (OTC:GWHP), as a action in the right route.

The Biden administration on Monday declared a huge thrust to make swift COVID-19 residence assessments readily available with a $230 million federal contract to an Australian organization.

The Department of Defense’s offer will allow Ellume to open up a U.S. factory and make 19 million quick tests every single thirty day period, 8.5 million of which will be furnished to the federal authorities, officials explained.

Ellume is the only corporation to get U.S. Foodstuff and Drug Administration authorization to make a property COVID-19 exam that does not have to have a lab or a healthcare provider’s prescription. The 15-minute take a look at involves a nasal swab for buyers to accumulate a sample and area into a cartridge and is made use of with a smartphone application that displays benefits.

When Ellume attained Fda authorization in December, the business reported it would provide the swift exams for $30. But the company did not have manufacturing capability to make the tests extensively out there to buyers.

On this announcement, Charles Strongo, CEO of Global WholeHealth Partners Corp., reported, “They should really occur discuss to us we have been accomplishing this for yrs.”

About Global:

World WholeHealth Companions Corp., a multinational provider of above 70+ with 56 merchandise Fda approved and many approved for export only like Dengue, Ebola, Zika, and Malaria and also presenting 1 of the major strains of tests for CoViD19 SARS2, is ready to assistance in the fight towards CoViD19 SARS2. With the pandemic out of control in the United States, the nation’s coronavirus tests system is starting to strain yet again.

About 30 million Covid-19 assessments are given each individual month, in accordance to estimates from The Atlantic magazine’s Covid Monitoring Project. But studies have observed that the U.S. would want tens of millions more—193 million a thirty day period, according to 1 report—to be productive.

The United states has the biggest variety of Covid-19 situations in the planet and there is issue that this following wave of bacterial infections will be even worse than the earlier. Worldwide WholeHealth Partners, Corp. is assured that its Covid-19 Fast Exam can make a distinction through aiding companies, personnel, and public destinations where by transmission may possibly arise with a trusted, accurate, and speedy Speedy Exam.

Global WholeHealth Partners Corp. gives reducing edge know-how employing In-vitro Diagnostic (IVD) Actual-Time PCR Machines for detection of SARS-CoV-2 IgM/IgG antibodies in human serum, plasma, or whole blood. It has led the fight towards vector borne terminal diseases these as Ebola, ZIKA, Dengue, Malaria, Influenza and Tuberculosis, Corona Viruses, and among the other vector borne health conditions. The company was established on March 7, 2013 and is headquartered in San Clemente, CA.


The Organization is not producing any convey or implied promises that its products has the means to reduce, overcome or comprise the Covid-19 (or SARS-2 Coronavirus) at this time.

Media Get hold of:

Name: Charles Strongo,

CEO, Global WholeHealth Companions Corp.

E mail:  [email protected]

Ahead-Hunting Statements

This press launch includes “forward-looking statements.”  This kind of statements may well be preceded by the words and phrases “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or identical text. Forward-on the lookout statements are not assures of foreseeable future effectiveness, are dependent on sure assumptions and are subject matter to several known and mysterious risks and uncertainties, numerous of which are further than the Company’s regulate, and can not be predicted or quantified and consequently, true final results may perhaps vary materially from those people expressed or implied by these types of forward-wanting statements. Such threats and uncertainties include, without having limitation, challenges and uncertainties linked with (i) market acceptance of our present and new products and solutions, (ii) negative clinical trial final results or lengthy product or service delays in vital markets, (iii) an inability to safe regulatory approvals for the sale of our goods, (iv) intensive level of competition in the medical gadget sector from considerably more substantial, multinational corporations, (v) products liability claims, (vi) product malfunctions, (vii) our limited producing capabilities and reliance on subcontractors for assistance, (viii) inadequate or insufficient reimbursement by governmental and other third get together payers for our goods, (ix) our initiatives to correctly get hold of and retain mental residence defense masking our merchandise, which may perhaps not be effective, (x) legislative or regulatory reform of the health care process in both of those the U.S. and foreign jurisdictions, (xi) our reliance on one suppliers for selected item components, (xii) the truth that we will want to elevate added cash to meet up with our enterprise specifications in the upcoming and that these funds elevating may well be pricey, dilutive or complicated to attain and (xiii) the reality that we carry out business in many international jurisdictions, exposing us to overseas currency trade level fluctuations, logistical and communications challenges, burdens and charges of compliance with overseas guidelines and political and economic instability in every single jurisdiction. Extra in depth facts about the Company and the danger things that could impact the realization of ahead-wanting statements is established forth in the Company’s filings with the Securities and Trade Fee (SEC), together with the Company’s Annual Report on Sort 10-K and its Quarterly Reports on Kind 10-Q. Buyers and stability holders are urged to examine these paperwork no cost of cost on the SEC’s world wide web website at The Enterprise assumes no obligation to publicly update or revise its forward-looking statements as a consequence of new info, foreseeable future gatherings or usually.